Staley Capital Advisers Inc. Grows Stake in Corteva, Inc. $CTVA

Staley Capital Advisers Inc. raised its position in shares of Corteva, Inc. (NYSE:CTVA) by 1.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 543,743 shares of the company’s stock after buying an additional 7,665 shares during the quarter. Corteva comprises 1.5% of Staley Capital Advisers Inc.’s portfolio, making the stock its 20th biggest holding. Staley Capital Advisers Inc.’s holdings in Corteva were worth $36,447,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Chilton Capital Management LLC grew its holdings in Corteva by 18.1% during the 3rd quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock valued at $30,119,000 after buying an additional 68,380 shares in the last quarter. Drummond Knight Asset Management Pty Ltd purchased a new position in shares of Corteva in the 4th quarter worth approximately $25,713,000. Truist Financial Corp boosted its holdings in shares of Corteva by 4.5% in the 3rd quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock worth $21,771,000 after purchasing an additional 13,910 shares during the period. Alberta Investment Management Corp purchased a new position in shares of Corteva in the 3rd quarter worth approximately $5,018,000. Finally, Nordea Investment Management AB boosted its holdings in shares of Corteva by 27.4% in the 3rd quarter. Nordea Investment Management AB now owns 75,675 shares of the company’s stock worth $5,103,000 after purchasing an additional 16,261 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Insider Activity

In related news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.15% of the company’s stock.

Corteva Price Performance

Shares of CTVA stock opened at $82.17 on Friday. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The firm has a market capitalization of $54.95 billion, a P/E ratio of 48.33, a P/E/G ratio of 2.52 and a beta of 0.59. The stock has a 50 day moving average price of $81.11 and a 200 day moving average price of $73.37.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same period last year, the company earned $1.13 EPS. Corteva’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts predict that Corteva, Inc. will post 3.7 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CTVA. Zacks Research cut Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Rothschild & Co Redburn lifted their target price on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Wall Street Zen cut Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. The Goldman Sachs Group lifted their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, April 14th. Finally, Wolfe Research lifted their target price on Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Thirteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $88.14.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.